- Home
- GTIM vs BTAI Comparison
GTIM vs BTAI Comparison
Compare GTIM & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- BTAI
- Stock Information
- Founded
- GTIM 1987
- BTAI 2017
- Country
- GTIM United States
- BTAI United States
- Employees
- GTIM N/A
- BTAI N/A
- Industry
- GTIM Restaurants
- BTAI Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- BTAI Health Care
- Exchange
- GTIM Nasdaq
- BTAI Nasdaq
- Market Cap
- GTIM 28.5M
- BTAI 28.7M
- IPO Year
- GTIM 1990
- BTAI 2018
- Fundamental
- Price
- GTIM $2.68
- BTAI $0.57
- Analyst Decision
- GTIM
- BTAI Strong Buy
- Analyst Count
- GTIM 0
- BTAI 4
- Target Price
- GTIM N/A
- BTAI $5.00
- AVG Volume (30 Days)
- GTIM 9.3K
- BTAI 465.8K
- Earning Date
- GTIM 12-12-2024
- BTAI 11-14-2024
- Dividend Yield
- GTIM N/A
- BTAI N/A
- EPS Growth
- GTIM N/A
- BTAI N/A
- EPS
- GTIM 0.10
- BTAI N/A
- Revenue
- GTIM $140,814,000.00
- BTAI $2,276,000.00
- Revenue This Year
- GTIM N/A
- BTAI $247.03
- Revenue Next Year
- GTIM N/A
- BTAI $88.16
- P/E Ratio
- GTIM $26.09
- BTAI N/A
- Revenue Growth
- GTIM 1.29
- BTAI 83.25
- 52 Week Low
- GTIM $2.15
- BTAI $0.50
- 52 Week High
- GTIM $3.45
- BTAI $4.17
- Technical
- Relative Strength Index (RSI)
- GTIM 43.57
- BTAI 44.39
- Support Level
- GTIM $2.70
- BTAI $0.51
- Resistance Level
- GTIM $2.82
- BTAI $0.61
- Average True Range (ATR)
- GTIM 0.08
- BTAI 0.07
- MACD
- GTIM -0.01
- BTAI -0.01
- Stochastic Oscillator
- GTIM 29.17
- BTAI 27.15
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; kids; breakfast; frozen custard; slides and drinks.
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.